Empagliflozin 12.5 mg + Metformin 500 mg Tablet | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Empagliflozin 12.5 mg + Metformin 500 mg Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: SGLT2 inhibitor (with combination partner if applicable)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Empagliflozin 12.5 mg + Metformin 500 mg Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Empagliflozin 12.5 mg + Metformin 500 mg Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Empagliflozin 12.5 mg + Metformin 500 mg Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Empagliflozin 12.5 mg + Metformin 500 mg formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Type-2 diabetes mellitus inadequately controlled by lifestyle measures or other oral agents
- Cardiovascular risk reduction in type-2 DM with established CV disease
- Heart failure with reduced or preserved ejection fraction
- Chronic kidney disease (CKD) protection in diabetic and non-diabetic patients
Mechanism of Action
Empagliflozin selectively inhibits SGLT2 in the proximal renal tubule, reducing glucose reabsorption and increasing urinary glucose excretion (about 70 g/day). The osmotic diuresis also reduces blood pressure and pre-load, contributing to its heart-failure and renoprotective benefits.
Dosage & Administration
- Take 1 tablet once daily in the morning, with or without food
- Swallow whole with water
- Ensure adequate hydration
- Use under physician supervision
Side Effects
- Genital mycotic infections (vulvovaginal candidiasis, balanitis)
- Urinary tract infections
- Polyuria and mild volume depletion
- Hypoglycaemia (mainly when combined with sulphonylureas or insulin)
- Diabetic ketoacidosis (rare; avoid with very low-carb diets, surgery)
Contraindications
- Type-1 diabetes
- History of diabetic ketoacidosis
- eGFR < 30 mL/min/1.73 m² (use restrictions vary)
- Pregnancy and breastfeeding
- Active urogenital infection
Storage
Store below 25°C.
PCD Pharma Franchise for Empagliflozin 12.5 mg + Metformin 500 mg Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 10 (Bliser)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Empagliflozin 12.5 mg + Metformin 500 mg Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Empagliflozin 12.5 mg + Metformin 500 mg Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Empagliflozin 12.5 mg + Metformin 500 mg Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Empagliflozin 12.5 mg + Metformin 500 mg Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Empagliflozin 12.5 mg + Metformin 500 mg Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Empagliflozin 12.5 mg + Metformin 500 mg Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Empagliflozin 12.5 mg + Metformin 500 mg Tablet?
Available pack sizes include: 10 x 10 (Bliser).
What is the MRP / trade price for Empagliflozin 12.5 mg + Metformin 500 mg Tablet?
MRPs range from ₹2020 to ₹2020 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Empagliflozin 12.5 mg + Metformin 500 mg Tablet?